Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
British Journal of Haematology
|
June 26, 2018
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols
Maddalena Paganin, Maria Francesca Grillo, Daniela Silvestri, et al.
Antioxidants (Basel, Switzerland)
|
March 29, 2023
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus
Micol Silic-Benussi, Evgeniya Sharova, Alberto Corradin, et al.
Experimental Hematology
|
June 27, 2006
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation
Sara Pozzi, Daniela Lisini, Marina Podestà, et al.
Nature Communications
|
May 7, 2026
CD84 is a specific target for acute myeloid leukemia CAR-T cell therapy
Martina Pigazzi, Silvia Merlini, Ambra Da Ros, et al.
Frontiers in Oncology
|
July 25, 2022
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia
Giulia Veltri, Federica Lovisa, Giuliana Cortese, et al.
Cytometry. Part B, Clinical Cytometry
|
July 25, 2014
Flow diagnostics essential code: a simple and brief format for the summary of leukemia phenotyping
Ondřej Hrušák, Giuseppe Basso, Richard Ratei, et al.
Blood Advances
|
January 23, 2026
Advancing Precision Therapy in Pediatric Acute Myeloid Leukemia Through PDX Models and Mitochondrial Targeting
Ambra Da Ros, Alberto Peloso, Giorgia Longo, et al.
Cells
|
October 12, 2018
A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia
Valeria Tosello, Gloria Milani, Annalisa Martines, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 30, 2023
FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report
Florian Kowarsch, Margarita Maurer-Granofszky, Lisa Weijler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow
Giuseppe Basso, Marinella Veltroni, Maria Grazia Valsecchi, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
British Journal of Haematology
|
June 26, 2018
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols
Maddalena Paganin, Maria Francesca Grillo, Daniela Silvestri, et al.
Antioxidants (Basel, Switzerland)
|
March 29, 2023
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus
Micol Silic-Benussi, Evgeniya Sharova, Alberto Corradin, et al.
Experimental Hematology
|
June 27, 2006
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation
Sara Pozzi, Daniela Lisini, Marina Podestà, et al.
Nature Communications
|
May 7, 2026
CD84 is a specific target for acute myeloid leukemia CAR-T cell therapy
Martina Pigazzi, Silvia Merlini, Ambra Da Ros, et al.
Frontiers in Oncology
|
July 25, 2022
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia
Giulia Veltri, Federica Lovisa, Giuliana Cortese, et al.
Cytometry. Part B, Clinical Cytometry
|
July 25, 2014
Flow diagnostics essential code: a simple and brief format for the summary of leukemia phenotyping
Ondřej Hrušák, Giuseppe Basso, Richard Ratei, et al.
Blood Advances
|
January 23, 2026
Advancing Precision Therapy in Pediatric Acute Myeloid Leukemia Through PDX Models and Mitochondrial Targeting
Ambra Da Ros, Alberto Peloso, Giorgia Longo, et al.
Cells
|
October 12, 2018
A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia
Valeria Tosello, Gloria Milani, Annalisa Martines, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 30, 2023
FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report
Florian Kowarsch, Margarita Maurer-Granofszky, Lisa Weijler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow
Giuseppe Basso, Marinella Veltroni, Maria Grazia Valsecchi, et al.
Page
of 9